These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6625312)

  • 21. Isolation of Campylobacter jejuni from experimental dogs and monkeys in Japan.
    Yoshimura M; Ebukuro M; Kagiyama N; Shimizu A; Saito Y
    Jikken Dobutsu; 1984 Apr; 33(2):209-12. PubMed ID: 6468516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Inhibitory and fatal activity of amoxicillin, erythromycin and josamycin against Streptococci].
    Savoia D; Angeretti A
    G Batteriol Virol Immunol; 1981; 74(7-12):283-96. PubMed ID: 7347699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Susceptibility of Campylobacter fetus subsp. jejuni to twenty-nine antimicrobial agents.
    Vanhoof R; Vanderlinden MP; Dierickx R; Lauwers S; Yourassowsky E; Butzler JP
    Antimicrob Agents Chemother; 1978 Oct; 14(4):553-6. PubMed ID: 718153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Sensitivities of clinical isolates to lincomycin and macrolide-type antibiotics (author's transl)].
    Deguchi K
    Jpn J Antibiot; 1981 Mar; 34(3):419-24. PubMed ID: 7289033
    [No Abstract]   [Full Text] [Related]  

  • 25. [Susceptibility of Campylobacter jejuni clinical isolates from children to eight antibiotics].
    García-Campos JA; Alarcón T; Domingo D; Menéndez-Rivas M; López-Brea M
    Rev Esp Quimioter; 2003 Jun; 16(2):216-20. PubMed ID: 12973460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Susceptibility of Campylobacter fetus subsp. jejuni to paromomycin.
    Freydiere AM; Barbé G; Gille Y; Vincent P
    Eur J Clin Microbiol; 1984 Aug; 3(4):322-3. PubMed ID: 6489324
    [No Abstract]   [Full Text] [Related]  

  • 27. Antimicrobial susceptibility of Campylobacter jejuni and Campylobacter fetus subsp. fetus to eight cephalosporins with special reference to species differentiation.
    Karmali MA; De Grandis S; Fleming PC
    Antimicrob Agents Chemother; 1980 Dec; 18(6):948-51. PubMed ID: 7235681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resistance to macrolide-lincosamide-streptogramin antibiotics in enterococci from the intestines of animals.
    Dutta GN; Devriese LA
    Res Vet Sci; 1982 Jul; 33(1):70-2. PubMed ID: 6813931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative efficacy of clindamycin, erythromycin and spiramycin against Staphylococcus aureus in the rat croton oil pouch model.
    Davey PG; Jacobus NV; Tally FP
    J Antimicrob Chemother; 1987 Nov; 20(5):705-12. PubMed ID: 3429372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Etiological significance of Campylobacter fetus subsp. jejuni and parvovirus in acute enteritis in the dog].
    Rübsamen S; Danner K; Weiss R
    Zentralbl Veterinarmed B; 1982 Aug; 29(7):521-31. PubMed ID: 7148215
    [No Abstract]   [Full Text] [Related]  

  • 31. Josamycin and rosamicin: in vitro comparisons with erythromycin and clindamycin.
    Shadomy S; Tipple M; Paxton L
    Antimicrob Agents Chemother; 1976 Oct; 10(4):773-5. PubMed ID: 984811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of a new macrolide, A-56268, compared with that of roxithromycin, erythromycin, and clindamycin.
    Barry AL; Thornsberry C; Jones RN
    Antimicrob Agents Chemother; 1987 Feb; 31(2):343-5. PubMed ID: 2952064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The susceptibility of anaerobic bacteria to rosamicin, erythromycin and clindamycin and factors affecting the activity of rosamicin.
    Kwok YY; Sutter VL; Oberhammer I; Finegold SM
    J Antimicrob Chemother; 1979 Jan; 5(1):61-6. PubMed ID: 33142
    [No Abstract]   [Full Text] [Related]  

  • 34. [Susceptibility of Streptococcus pyogenes to macrolides and quinolones in Guadalajara, Spain].
    Rodríguez-Zurita ME; Solís del Baño S; Robres Guillén P; González Praetorius A; Gimeno Fernández C; Pérez Pomata MT; Bisquert Santiago J
    Rev Esp Quimioter; 2003 Mar; 16(1):61-4. PubMed ID: 12750759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hippurate hydrolysis by and triphenyltetrazolium tolerance of Campylobacter fetus.
    Luechtefeld NW; Wang WL
    J Clin Microbiol; 1982 Jan; 15(1):137-40. PubMed ID: 7186902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of the in vitro activity of rosamicin, erythromycin, clindamycin, metroidazole and ornidazole against Haemophilus ducreyi, including beta-lactamase producing strains.
    Feltham S; Ronald AR; Albritton WL
    J Antimicrob Chemother; 1979 Nov; 5(6):731-4. PubMed ID: 317079
    [No Abstract]   [Full Text] [Related]  

  • 37. Multidrug resistance in Campylobacter jejuni strains collected from Finnish patients during 1995-2000.
    Hakanen AJ; Lehtopolku M; Siitonen A; Huovinen P; Kotilainen P
    J Antimicrob Chemother; 2003 Dec; 52(6):1035-9. PubMed ID: 14613954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence, antimicrobial susceptibility and molecular characterization of Campylobacter isolates recovered from humans and poultry in Lebanon.
    Talhouk RS; el-Dana RA; Araj GF; Barbour E; Hashwa F
    J Med Liban; 1998; 46(6):310-6. PubMed ID: 10349269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ferret as a potential reservoir for human campylobacteriosis.
    Fox JG; Ackerman JI; Newcomer CE
    Am J Vet Res; 1983 Jun; 44(6):1049-52. PubMed ID: 6870007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cluster of erythromycin- and ciprofloxacin-resistant Campylobacter jejuni subsp. jejuni from 1999 to 2001 in men who have sex with men, Québec, Canada.
    Gaudreau C; Michaud S
    Clin Infect Dis; 2003 Jul; 37(1):131-6. PubMed ID: 12830417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.